Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 301–400 of 1,015
Programmed Cell Death, from a Cancer Perspective: An Overview
Mishra, A. P., Salehi, B., Sharifi-Rad, M., Pezzani, R., Kobarfard, F., Sharifi-Rad, J., & Nigam, M. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0329-9 · Cited by 190
Unilateral ureteral obstruction: beyond obstruction
Ucero, A. C., Benito-Martin, A., Izquierdo, M. C., Sanchez-Niño, M. D., Sanz, A. B., Ramos, A. M., Berzal, S., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2014) · International Urology and Nephrology · doi:10.1007/s11255-013-0520-1 · Cited by 189
McComb, S., Cessford, E., Alturki, N. A., Joseph, J., Shutinoski, B., Startek, J. B., Gamero, A. M., Mossman, K. L., & Sad, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407068111 · Cited by 190
“Most studies on necroptosis involve evaluation of the signaling mechanisms in nonimmune cells (28), in which case necroptosis most commonly is induced by stimulating cells with TNF-α in the absence of caspase signaling (benzyloxycarbonyl-Val-Ala-Aspfluoromethylketone, zVAD-FMK) (29).”
BackgroundMethodPUMA amplifies necroptosis signaling by activating cytosolic DNA sensors
Chen, D., Tong, J., Yang, L., Wei, L., Stolz, D. B., Yu, J., Zhang, J., & Zhang, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717190115 · Cited by 177
“1A), including loss of cell viability by crystal violet staining (5), depletion of intracellular ATP (5), propidium iodide (PI) staining for nonapoptotic death, extracellular release of nuclear High-Mobility Group Box 1 (HMGB1) (16), and inhibition of cell death by the RIP1 inhibitor necrostatin-1 (Nec-1; N) (17).”
BackgroundRoles of RIPK3 in necroptosis, cell signaling, and disease
Morgan, M. J., & Kim, Y.-S. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00868-z · Cited by 184
Necroptosis in Immunity and Ischemia-Reperfusion Injury
Linkermann, A., Hackl, M. J., Kunzendorf, U., Walczak, H., Krautwald, S., & Jevnikar, A. M. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12448 · Cited by 188
“The first model in which the RIPK1-inhibitor (Nec-1) was shown to be protective was cerebral IRI (9), even prior to confirming that the kinase domain of RIPK1 was the therapeutic target (10).”
BackgroundComplex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis
Wegner, K. W., Saleh, D., & Degterev, A. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.005 · Cited by 186
Self-citationGuidelines and recommendations on yeast cell death nomenclature
Carmona-Gutierrez, D., Bauer, M. A., Zimmermann, A., Aguilera, A., Austriaco, N., Ayscough, K., Balzan, R., Bar-Nun, S., Barrientos, A., Belenky, P., et al. (2018) · Microbial Cell · doi:10.15698/mic2018.01.607 · Cited by 188
How neurons die in Alzheimer's disease: Implications for neuroinflammation
Mangalmurti, A., & Lukens, J. R. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102575 · Cited by 186
Participation of autophagy in renal ischemia/reperfusion injury
Suzuki, C., Isaka, Y., Takabatake, Y., Tanaka, H., Koike, M., Shibata, M., Uchiyama, Y., Takahara, S., & Imai, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.059 · Cited by 184
Shchors, K., Massaras, A., & Hanahan, D. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.012 · Cited by 187
“In addition, the inhibition of necroptosis (programmed cell death by necrosis) by necrostatin-1 (25 mM), a small-molecular inhibitor of necroptosis (Degterev et al., 2005), did not block IM+TIC-induced cell death (Figures 3I and 3J).”
BackgroundLinking Pathogenic Mechanisms of Alcoholic Liver Disease With Clinical Phenotypes
Nagy, L. E., Ding, W.-X., Cresci, G., Saikia, P., & Shah, V. H. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.035 · Cited by 184
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Yang, H., Ma, Y., Chen, G., Zhou, H., Yamazaki, T., Klein, C., Pietrocola, F., Vacchelli, E., Souquere, S., Sauvat, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1149673 · Cited by 185
Deng, X.-X., Li, S.-S., & Sun, F.-Y. (2019) · Aging and disease · doi:10.14336/ad.2018.0728 · Cited by 182
“In this study, we used a MCAO model in rats combined with different approaches to investigate the possible roles of RIPK1-triggered RIPK3/MLKL-dependent necroptosis in the pathogenesis of ischemic brain injury.”
BackgroundMethodInfluentialFlipping the dogma – phosphatidylserine in non-apoptotic cell death
Shlomovitz, I., Speir, M., & Gerlic, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0437-0 · Cited by 189
DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer
Paludan, S. R., Reinert, L. S., & Hornung, V. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-018-0117-0 · Cited by 186
Necroptosis: an alternative cell death program defending against cancer
Chen, D., Yu, J., & Zhang, L. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.03.003 · Cited by 182
The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis
Fu, Z., Deng, B., Liao, Y., Shan, L., Yin, F., Wang, Z., Zeng, H., Zuo, D., Hua, Y., & Cai, Z. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-580 · Cited by 180
“As a potent necroptosis inhibitor, Nec-1 was previously believed not to inhibit apoptosis [7,14,21].”
BackgroundCell death regulation: A new way for natural products to treat osteoporosis
Li, Z., Li, D., Chen, R., Gao, S., Xu, Z., & Li, N. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2022.106635 · Cited by 177
Fluorescent Proteins as Genetically Encoded FRET Biosensors in Life Sciences
Hochreiter, B., Pardo-Garcia, A., & Schmid, J. (2015) · Sensors · doi:10.3390/s151026281 · Cited by 180
“Necroptosis was first described in 2005 [108], and is an important mechanism in the reaction of the immune system to viruses, as well as acute pancreatitis, ischemic injury and septic shock, especially if the apoptosis pathway is pharmacologically or genetically inhibited [109].”
BackgroundBenetatos, C. A., Mitsuuchi, Y., Burns, J. M., Neiman, E. M., Condon, S. M., Yu, G., Seipel, M. E., Kapoor, G. S., LaPorte, M. G., Rippin, S. R., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0798 · Cited by 178
“Necrostatin 1 (Nec-1), a RIPK1 inhibitor (37),”
Chen, J., Kos, R., Garssen, J., & Redegeld, F. (2019) · Cells · doi:10.3390/cells8121486 · Cited by 178
“Necrostatins (necrostatin-1, 7-Cl-O-necrostatin) RIPK1 [1,41]”
BackgroundDara, L., Johnson, H., Suda, J., Win, S., Gaarde, W., Han, D., & Kaplowitz, N. (2015) · Hepatology · doi:10.1002/hep.27939 · Cited by 176
“The first studies showing the role of RIPK1 in necroptosis were carried out with the kinase inhibitor, necrostatin 1 (nec-1), which protects mice against cardiac myocyte necrosis, renal ischemia reperfusion injury, retinal photoreceptor necrosis, and TNF-induced systemic inflammation, among other disease models.(18-23…”
BackgroundAutophagy is required for necrotic cell death in Caenorhabditis elegans
Samara, C., Syntichaki, P., & Tavernarakis, N. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402231 · Cited by 178
Cell Death and DAMPs in Acute Pancreatitis
Kang, R., Lotze, M. T., Zeh, H. J., Billiar, T. R., & Tang, D. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00117 · Cited by 178
Huang, Z., Zhou, T., Sun, X., Zheng, Y., Cheng, B., Li, M., Liu, X., & He, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.141 · Cited by 175
“It could block the interaction between RIP1 and RIP3 and inhibit the formation of necroptotic complex.(32) In this study, we found Nec-1 treatment not only reduced the expression levels of RIP1, RIP3 and MLKL, but also significantly suppressed TUNEL staining on microglia, indicating the RIP1-RIP3-MLKL pathway was requ…”
BackgroundSelf-citationGovender, J., Loos, B., Marais, E., & Engelbrecht, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12176 · Cited by 176
“Necrostatin-1 (Nec-1), a potent inhibitor of necroptosis [136] in combination with an apoptotic inhibitor, has been shown to protect the heart against ischemic injury.”
BackgroundAIF‐mediated caspase‐independent necroptosis: A new chance for targeted therapeutics
Delavallée, L., Cabon, L., Galán‐Malo, P., Lorenzo, H. K., & Susin, S. A. (2011) · IUBMB Life · doi:10.1002/iub.432 · Cited by 178
“However, TNFR1-mediated necroptosis cannot be blocked by inhibition of calpains and PARP-1 or by downregulation of AIF (61), whereas MNNG-mediated necroptosis is not abolished in TNFR1-deficient MEFs (55).”
BackgroundAccumulation of autophagosomes confers cytotoxicity
Button, R. W., Roberts, S. L., Willis, T. L., Hanemann, C. O., & Luo, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.782276 · Cited by 179
“Apoptosis is inhibited by the pan-caspase inhibitor benzyloxycarbonyl-VADfluoromethyl ketone (Z-VAD-fmk) (36), and necroptosis can be blocked by necrostatin-1 (Nec) (37), a selective inhibitor of RIP1 that is essential for RIP1-RIP3-dependent necroptosis (38 – 40).”
BackgroundBaek, S.-H., Noh, A. R., Kim, K.-A., Akram, M., Shin, Y.-J., Kim, E.-S., Yu, S. W., Majid, A., & Bae, O.-N. (2014) · Stroke · doi:10.1161/strokeaha.114.005183 · Cited by 174
“Although controversy exists whether autophagy contributes to cell death or cell survival, recent observations using inhibitors or modulators of autophagy revealed that autophagy mediates neuronal cell death during ischemia.(12,13) Wen et al(14) observed autophagy in focal cerebral ischemia and demonstrated that treatm…”
Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation
Kim, E. H., Wong, S.-W., & Martinez, J. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0179-3 · Cited by 177
Sonkusre, P., & Cameotra, S. S. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0276-3 · Cited by 175
Necroptotic cell death in anti‐cancer therapy
Krysko, O., Aaes, T. L., Kagan, V. E., D'Herde, K., Bachert, C., Leybaert, L., Vandenabeele, P., & Krysko, D. V. (2017) · Immunological Reviews · doi:10.1111/imr.12583 · Cited by 173
The Diversification of Cell Death and Immunity: Memento Mori
Legrand, A. J., Konstantinou, M., Goode, E. F., & Meier, P. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.006 · Cited by 172
Xu, X., Chua, C. C., Kong, J., Kostrzewa, R. M., Kumaraguru, U., Hamdy, R. C., & Chua, B. H. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04884.x · Cited by 176
“Recently, a novel type of cell death called necroptosis was identified by Degterev et al. (2005).”
BackgroundResultInfluentialMurakami, Y., Matsumoto, H., Roh, M., Suzuki, J., Hisatomi, T., Ikeda, Y., Miller, J. W., & Vavvas, D. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206937109 · Cited by 171
“that autophagy is induced during RIP kinase-mediated necrosis but is not critical for cell death (19).”
New Insights into the Mechanisms for Photodynamic Therapy-Induced Cancer Cell Death
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394306-4.00010-1 · Cited by 173
“However, accumulating evidence indicates that necrotic cell death may be executed by specific mechanisms, including signal transduction (Christofferson and Yuan, 2010; Degterev et al., 2005; Galluzzi and Kroemer, 2008; Golstein and Kroemer, 2007).”
BackgroundOvermeyer, J. H., Young, A. M., Bhanot, H., & Maltese, W. A. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-69 · Cited by 171
“, oncosis [8-10], necroptosis [11,12] and paraptosis [13,14].”
BackgroundLim, S. Y., Davidson, S. M., Mocanu, M. M., Yellon, D. M., & Smith, C. C. T. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6067-6 · Cited by 175
“[1] The cytoprotective effect of Nec-1 was first demonstrated by Degterev et al.”
InfluentialVural, D. F., Cebesoy, S., & Karakaş, M. F. (2013) · Journal of Entomology and Zoology Studies · Cited by 172
Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP / PS 1 mice
Yang, S., Lee, D. K., Shin, J., Lee, S., Baek, S., Kim, J., Jung, H., Hah, J., & Kim, Y. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606566 · Cited by 171
“The small molecule necrostatin-1 (Nec-1) is a wellestablished inhibitor of necroptotic cell death, also known as necroptosis (Degterev et al, 2005).”
BackgroundInhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
Shahar, N., & Larisch, S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100712 · Cited by 165
Absence of RIPK3 predicts necroptosis resistance in malignant melanoma
Geserick, P., Wang, J., Schilling, R., Horn, S., Harris, P. A., Bertin, J., Gough, P. J., Feoktistova, M., & Leverkus, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.240 · Cited by 169
“To further elaborate the role of RIPK1/RIPK3 activities in necroptosis execution, we analysed cell death responses of RIPK3-expressing melanoma cells in the presence of the RIPK1 inhibitor Necrostatin-1 (Nec-1) in more detail.(31) Inhibition of RIPK1 alone did not alter CD95L-induced cell death when IAPs were suppress…”
BackgroundPouwels, S. D., Zijlstra, G. J., van der Toorn, M., Hesse, L., Gras, R., ten Hacken, N. H. T., Krysko, D. V., Vandenabeele, P., de Vries, M., van Oosterhout, A. J. M., et al. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00174.2015 · Cited by 166
MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis
Liu, S., Liu, H., Johnston, A., Hanna-Addams, S., Reynoso, E., Xiang, Y., & Wang, Z. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707531114 · Cited by 169
“Compound necrostatin-1 (Nec-1) blocks RIPK1 activity (38), which is not required for necroptosis in the NTD-DmrB cells.”
BackgroundVandenabeele, P., Grootjans, S., Callewaert, N., & Takahashi, N. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.151 · Cited by 163
Necrosome core machinery: MLKL
Zhang, J., Yang, Y., He, W., & Sun, L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2190-5 · Cited by 165
“The first well-defined necroptosis inhibitor is necrostatin-1 (Nec-1), which blocks necroptosis by targeting RIP1 kinase activity [54, 55].”
BackgroundAdvances in stroke pharmacology
Zhou, Z., Lu, J., Liu, W.-W., Manaenko, A., Hou, X., Mei, Q., Huang, J.-L., Tang, J., Zhang, J. H., Yao, H., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.012 · Cited by 163
Riding the metal wave: A review of the latest developments in metal-based anticancer agents
Abdolmaleki, S., Aliabadi, A., & Khaksar, S. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215579 · Cited by 169
Role and mechanisms of autophagy in acetaminophen‐induced liver injury
Chao, X., Wang, H., Jaeschke, H., & Ding, W. (2018) · Liver International · doi:10.1111/liv.13866 · Cited by 163
Sosna, J., Voigt, S., Mathieu, S., Lange, A., Thon, L., Davarnia, P., Herdegen, T., Linkermann, A., Rittger, A., Chan, F. K.-M., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1381-6 · Cited by 162
“In Jurkat and BALB/c 3T3 cells, necroptotic cell death could not be blocked by small-molecule inhibition of factors such as calpains and PARP-1, or the downregulation of AIF by RNA interference [38].”
Killing a cancer: what are the alternatives?
Kreuzaler, P., & Watson, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3264 · Cited by 161
Duan, X., Liu, X., Liu, N., Huang, Y., Jin, Z., Zhang, S., Ming, Z., & Chen, H. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2328-0 · Cited by 159
Sawai, H., & Domae, N. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.186 · Cited by 162
Rodrigue-Gervais, I. G., Labbé, K., Dagenais, M., Dupaul-Chicoine, J., Champagne, C., Morizot, A., Skeldon, A., Brincks, E. L., Vidal, S. M., Griffith, T. S., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2013.12.003 · Cited by 161
Interactions between bacterial pathogens and mitochondrial cell death pathways
Rudel, T., Kepp, O., & Kozjak-Pavlovic, V. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2421 · Cited by 169
Necroptosis, in vivo detection in experimental disease models
Jouan-Lanhouet, S., Riquet, F., Duprez, L., Vanden Berghe, T., Takahashi, N., & Vandenabeele, P. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.08.010 · Cited by 162
“Interestingly, Nec-1 administration reduced the infarct size and inflammation caused by myocardial IR [80, 99, 112] and reduced tissue injury upon cerebral [91, 113], retinal [100] or renal IR [114, 115] and neonatal hypoxia-ischemia in the brain [116, 117], by preventing oxidative stress, necrosis and inflammation.”
BackgroundMethodInfluentialBrain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities
Liu, W., Wang, X., O’Connor, M., Wang, G., & Han, F. (2020) · Neural Plasticity · doi:10.1155/2020/1969482 · Cited by 160
“In addition to apoptosis, a few novel types of cell death that play significant roles in the pathologic process of stroke have been identified, such as autophagy [53], necroptosis [10, 54], ferroptosis [55], parthanatos [56], and pyroptosis [57].”
BackgroundInnate immune inflammatory cell death: PANoptosis and PANoptosomes in host defense and disease
Chen, W., Gullett, J. M., Tweedell, R. E., & Kanneganti, T. (2023) · European Journal of Immunology · doi:10.1002/eji.202250235 · Cited by 173
“Necroptosis is another lytic form of cell death which takes place when caspase-8 is inhibited or absent, leading to the phosphorylation and oligomerization of the pore-forming protein MLKL [21–26].”
BackgroundResearch progress on morphology and mechanism of programmed cell death
Chen, Y., Li, X., Yang, M., & Liu, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06712-8 · Cited by 187
“Necroptosis is a form of PCD that is controlled by a unique caspase-independent signaling pathway and has necrosis-like morphological characteristics [15].”
BackgroundInvolvement of autophagy in hypoxic-excitotoxic neuronal death
Ginet, V., Spiehlmann, A., Rummel, C., Rudinskiy, N., Grishchuk, Y., Luthi-Carter, R., Clarke, P. G., Truttmann, A. C., & Puyal, J. (2014) · Autophagy · doi:10.4161/auto.28264 · Cited by 159
Naito, M. G., Xu, D., Amin, P., Lee, J., Wang, H., Li, W., Kelliher, M., Pasparakis, M., & Yuan, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916427117 · Cited by 158
“While apoptosis has been shown to transition into necroptosis on inhibition of caspases (2, 7), it is unclear whether necroptosis may also transition into apoptosis and, if so, what conditions may mediate this transition.”
BackgroundMethodInfluentialSelf-citationGünther, C., He, G.-W., Kremer, A. E., Murphy, J. M., Petrie, E. J., Amann, K., Vandenabeele, P., Linkermann, A., Poremba, C., Schleicher, U., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87545 · Cited by 157
“While for a long time apoptosis and necrosis were the most widely recognized forms of cell death, the concept of regulated cell death was recently challenged by the discovery of necroptosis (1, 2).”
BackgroundFas-associated death domain (FADD) is a negative regulator of T-cell receptor–mediated necroptosis
Osborn, S. L., Diehl, G., Han, S.-J., Xue, L., Kurd, N., Hsieh, K., Cado, D., Robey, E. A., & Winoto, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005997107 · Cited by 156
“This process, termed programmed necrosis or necroptosis (5), is independent from caspases and can be triggered by the tumor necrosis factor (TNF) death receptors (e.”
BackgroundLai, Z.-W., Borsuk, R., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Francis, L., Tily, H., Bartos, A., Faraone, S. V., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301005 · Cited by 155
“Although necroptosis was initially implicated in mouse ischemic brain injury (34), neurodegeneration, and infection (39), it has”
BackgroundXie, X., Zhao, Y., Ma, C., Xu, X., Zhang, Y., Wang, C., Jin, J., Shen, X., Gao, J., Li, N., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13184 · Cited by 155
“Necroptosis is a necrotic-like, caspase-independent cell death that is characterized by loss of plasma membrane integrity, excessive autophagy, loss of mitochondria membrane potential and the generation of reactive oxygen species (ROS) is enhanced in necrotic cells (Degterev et al., 2005).”
BackgroundTissue acidosis induces neuronal necroptosis via ASIC1a channel independent of its ionic conduction
Wang, Y., Wang, J.-J., Huang, Y., Liu, F., Zeng, W.-Z., Li, Y., Xiong, Z.-G., Zhu, M. X., & Xu, T.-L. (2015) · eLife · doi:10.7554/elife.05682 · Cited by 165
“Consistent with previous reports (Degterev et al., 2005, 2008), we observed increased RIP1 phosphorylation in ischemic brain fromWT mice, which was successfully removed by treating the RIP1 immunoprecipitant for 1 hr with a bovine intestinal alkaline phosphatase (Figure 5E, upper).”
BackgroundMethodInfluentialSelf-citationMitochondrial Protein PGAM5 Regulates Mitophagic Protection against Cell Necroptosis
Lu, W., Sun, J., Yoon, J. S., Zhang, Y., Zheng, L., Murphy, E., Mattson, M. P., & Lenardo, M. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147792 · Cited by 156
“These include the early incorporation of propidium iodide indicating membrane breakdown (Fig 2A, panels c and d) and the blockade of TCZ-induced cell death of MEFs by the RIP1 kinase inhibitor necrostatin-1 (Nec1) [31] or the reactive oxygen species (ROS) scavenger butylated hydroxyanisole (BHA) [29] (Fig 2B).”
BackgroundRIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD
Chen, H., Fang, Y., Wu, J., Chen, H., Zou, Z., Zhang, X., Shao, J., & Xu, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0936-8 · Cited by 163
Magtanong, L., & Dixon, S. J. (2018) · Developmental Neuroscience · doi:10.1159/000496922 · Cited by 155
Regulated Necrotic Cell Death: The Passive Aggressive Side of Bax and Bak
Karch, J. M., & Molkentin, J. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.305421 · Cited by 180
Liu, S., Li, Y., Choi, H. M. C., Sarkar, C., Koh, E. Y., Wu, J., & Lipinski, M. M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0469-1 · Cited by 153
Self-citationProgrammed necrosis and necroptosis signalling
Feoktistova, M., & Leverkus, M. (2015) · The FEBS Journal · doi:10.1111/febs.13120 · Cited by 152
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Najjar, M., Suebsuwong, C., Ray, S. S., Thapa, R. J., Maki, J. L., Nogusa, S., Shah, S., Saleh, D., Gough, P. J., Bertin, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.052 · Cited by 147
“1A) (Degterev et al., 2008; Degterev et al., 2005).”
Self-citationRIP1/RIP3-regulated necroptosis as a target for multifaceted disease therapy (Review)
Liu, Y., Liu, T., Lei, T., Zhang, D., Du, S., Girani, L., Qi, D., Chen, L., Tong, R., & Wang, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4244 · Cited by 201
“Nec-1 RIP1 Nec-1 is the most active, compared with (2)”
BackgroundInfluentialThe molecular regulation of programmed necrotic cell injury
Moquin, D., & Chan, F. K.-M. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.03.001 · Cited by 154
Gong, K., & Li, W. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.018 · Cited by 159
“Nec-1 has been reported to be a specific inhibitor of RIP1 [41].”
BackgroundOxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells
Lin, W.-J., & Kuang, H.-Y. (2014) · Autophagy · doi:10.4161/auto.36076 · Cited by 154
Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
Berger, S., Harris, P., Nagilla, R., Kasparcova, V, Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Ouellette, M., et al. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.9 · Cited by 148
Release of Interleukin-1α or Interleukin-1β Depends on Mechanism of Cell Death
England, H., Summersgill, H. R., Edye, M. E., Rothwell, N. J., & Brough, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557561 · Cited by 152
“However, necroptosis is known to require the formation of a pro-necroptotic complex containing the kinases RIP1 and RIP3 (30, 31) and is inhibited by the RIP1 inhibitor NEC1 (23, 24).”
BackgroundInfluentialTakemoto, K., Hatano, E., Iwaisako, K., Takeiri, M., Noma, N., Ohmae, S., Toriguchi, K., Tanabe, K., Tanaka, H., Seo, S., et al. (2014) · FEBS Open Bio · doi:10.1016/j.fob.2014.08.007 · Cited by 151
“Moreover, a RIPK1 inhibitor ameliorated APAP-induced hepatotoxicity in an animal model, which was underscored by significant suppression of the release of hepatic enzymes and cytokine expression levels.”
BackgroundThe Role of Necroptosis in Cardiovascular Disease
Shi, Z., Li‐Sha, G., & Li, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00721 · Cited by 166
Self-citationFarr, A. C., & Xiong, M. P. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00474 · Cited by 146
Galluzzi, L., Berghe, T. V., Vanlangenakker, N., Büttner, S., Eisenberg, T., Vandenabeele, P., Madeo, F., & Kroemer, G. (2011) · International review of cytology · doi:10.1016/b978-0-12-386039-2.00001-8 · Cited by 181
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1
Moujalled, D. M., Cook, W. D., Okamoto, T., Murphy, J., Lawlor, K. E., Vince, J. E., & Vaux, D. L. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.201 · Cited by 149
The Structural Basis of Necroptotic Cell Death Signaling
Petrie, E. J., Czabotar, P. E., & Murphy, J. M. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.11.002 · Cited by 153
Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke
Zhou, Y., Liao, J., Mei, Z., Liu, X., & Ge, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9991001 · Cited by 164
“These above indicate that stimulation of the Fas/TNFR family triggers cell death and then aggravates cerebral ischemia and CIRI [6, 129].”
BackgroundViral modulation of programmed necrosis
Kaiser, W. J., Upton, J. W., & Mocarski, E. S. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.05.019 · Cited by 151
“This leads to two alternatives: activation of NF-kB independent of RIP1 kinase activity [39] and triggering necrosis dependent on kinase activity [58 ,59].”
MethodAkt and mTOR mediate programmed necrosis in neurons
Liu, Q., Qiu, J., Liang, M., Golinski, J., van Leyen, K., Jung, J. E., You, Z., Lo, E. H., Degterev, A., & Whalen, M. J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.69 · Cited by 151
“but ROS production does not occur, and Akt inhibitors block TNF production but not cell death in this line.(2,23) Thus, no simple relationship exists between Akt/mTOR activation,”
InfluentialSelf-citationcIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation
McComb, S., Cheung, H. H., Korneluk, R. G., Wang, S., Krishnan, L., & Sad, S. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.59 · Cited by 148
“Programmed necrosis (necroptosis) can be specifically blocked by necrostatin-1 (Nec-1), a small-molecule inhibitor of the kinase activity of receptor interacting protein 1 (Rip1).(8)”
BackgroundControl of infection by pyroptosis and autophagy: role of TLR and NLR
Bortoluci, K. R., & Medzhitov, R. M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0335-5 · Cited by 177
“RIP1, a death-domain-containing kinase associated with the death receptors seems to be dispensable for the induction of death-receptor-mediated apoptosis [37], but it is essential for this caspase-independent cell death, suggesting the concept of a distinct mechanism of regulated cell death from apoptosis [38, 39].”
BackgroundXu, X., Chua, K., Chua, C. C., Liu, C., Hamdy, R. C., & Chua, B. H. L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.080 · Cited by 153
“Importantly, they identified a specific necroptosis inhibitor necrostatin-1 (Nec-1) that reduced the infarct volume in a cerebral ischemia/ reperfusion mouse model even when it was administered 6 h after reperfusion (Degterev et al., 2005).”
BackgroundInfluentialSaito, N., Qiao, H., Yanagi, T., Shinkuma, S., Nishimura, K., Suto, A., Fujita, Y., Suzuki, S., Nomura, T., Nakamura, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008227 · Cited by 156
“Apoptosis is dependent on the activation of caspases; necroptosis is not influenced by caspase inhibition but is blocked by necrostatin-1 (Nec-1), an inhibitor of the kinase activity of RIP1 and by RIP3 inhibition (9).”
BackgroundWang, J.-Y., Xia, Q., Chu, K.-T., Pan, J., Sun, L.-N., Zeng, B., Zhu, Y.-J., Wang, Q., Wang, K., & Luo, B.-Y. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31821352bd · Cited by 147
“The concepts of ‘‘apoptotic-necrotic continuum’’ (3, 21), ‘‘paraptosis’’ (39), ‘‘necroptosis’’ (6), or ‘‘pathological apoptosis’’ (23) have also been proposed to portray this kind of neuronal death.”
Feng, Z., Wang, H., Chen, X., & Xu, B. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b07147 · Cited by 148
Meng, H., Liu, Z., Li, X., Wang, H., Jin, T., Wu, G., Shan, B., Christofferson, D. E., Qi, C., Yu, Q., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722013115 · Cited by 150
“While artificial dimerization of the truncated RIPK1 kinase domain has long been known to be able to activate its kinase activity (30), the molecular mechanism that may promote the dimerization of RIPK1 under physiological conditions has been unclear until now.”
BackgroundSelf-citationLysosomal quality control of cell fate: a novel therapeutic target for human diseases
Zhu, S., Yao, R.-Q., Li, Y., Zhao, P., Ren, C., Du, X., & Yao, Y.-M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03032-5 · Cited by 161
Self-citationYahiro, K., Satoh, M., Nakano, M., Hisatsune, J., Isomoto, H., Sap, J., Suzuki, H., Nomura, F., Noda, M., Moss, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387498 · Cited by 147
“Necrostatin-1, which inhibits necroptosis (44), did not interfere with VacA-induced generation of LC3-II and PARP cleavage.”
Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia
Kim, S. J., & Li, J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.238 · Cited by 145
Different types of cell death and their shift in shaping disease
Shen, S., Shao, Y., & Li, C. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01581-0 · Cited by 165
“Finally, the necrosome transfer from cytoplasm to cell membrane or organelle membrane to form permeable pores, destroy integrity of membrane, thus result in necroptosis [41, 45 – 47].”
Background
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.